Members of Sisram Medical�s management team and board of directors will host a conference call to discuss the first half financial results in more detail on Monday, August 22, 2022, at 8:30 a.m. Eastern Time. Speakers will include Mr. Liu YI, Sisram�s Chairman and Executive Director, and Mr. Lior DAYAN, Sisram�s Chief Executive Officer, Mr. Guojun BU, Sisram�s CFO, Mr. Doron YANNAI, Alma�s CFO, Ms. Qianli FANG, Sisram�s Company Secretary, Investment & IR Director, following the prepared remarks they will also be available for a Q&A session.

The Company encourages participants to pre-register for the conference call using the follow link: https://AlmaLasers.activetrail.biz/Sisram-IR-form. Callers will receive dial-in details upon registration, which enables immediate access on the day of the call. Participants may pre-register at any time, including up to and after the call start time.

The conference call will be commenced at:

8:30 a.m. Eastern Time
5:30 a.m. Pacific Time
3:30 p.m. Israel Time

A replay will also be available on Sisram Medical�s Event�s page at: https://sisram-medical.com/investors/events-presentations/.

Hashtag: #SisramMedical

The issuer is solely responsible for the content of this announcement.

About Sisram Medical Ltd

Sisram Medical Ltd ( 1696.HK) is a global consumer wellness group, featuring a first-of-its-kind synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics devices, injectables therapy, aesthetic and digital dentistry, personal care and more. The company is majority-owned by Fosun Pharma, one of China�s leading healthcare groups. On September 19, 2017, Sisram Medical went public, becoming the first Israeli company ever to trade on the Main Board of the Hong Kong Exchange.

Sisram Medical � Enhancing Quality of Life
http://www.sisram-medical.com

Investor Relations Contact:

[email protected]